corbevax

The world now has a new COVID-19 vaccine in its arsenal, and at a fraction of the cost per dose. Two years into the COVID-19 pandemic, the world has seen over 314 million infections…

The Subject Expert Committee (SEC) recommended granting of permission to conduct proposed phase 3 clinical trials for boosters of biological vaccine subject to the two conditions: …

COVOVAX, the nanoparticle vaccine, was granted emergency use approval by the World Health Organization (WHO) earlier this month. The WHO had said…

“Models of what India-United States healthcare collaboration can achieve for global good!” Sandhu India-US collaboration in the health sector is in the spotlight as the Central Drug…

The company said it has reached production levels of 75 million doses per month at present and would make 100 plus million doses per month from February 2022.  Hyderabad-based Biological E…

New Delhi, December 28  An expert panel of the country's central drug authority has recommended granting emergency use authorisation to the…

The SEC on COVID-19 of the CDSCO, which reviewed the emergency use authorisation (EUA) applications of Serum Institute of India (SII) for the second time on Monday, after detailed…

If and when the recommendation for a booster is made, beneficiaries vaccinated with Covishield, Sputnik V, and are likely to have multiple options. (File)A Covid-19 booster dose, when…

Biological E Managing Director Mahima DatlaCall it a tale of two leading vaccine makers from the same city. Biological E, yet another company from Hyderabad after Bharat Biotech, is now…

Everything about Biological E Corbevax vaccine (Representative Image, IE)Corbevax has secured permission for the third phase clinical trials of the vaccine and the government is expecting…